发明名称
摘要 3-substituted 1-arylindole compound having general Formula I <CHEM> wherein Ar is an optionally substituted aryl group; X represents a bond, a divalent hydrocarbon group or methyleneoxy or -thioxo; R<1>_R<4> are hydrogen or substituents; R<5> is hydrogen, hydroxy, alkoxy, halogen, trifluoromethyl, alkyl or alkenyl; R<6> and R<7> are hydrogen, alkyl or alkenyl; R<8> is alkyl or alkenyl a group of Formula 1a or 1b : <CHEM> wherein; W is O or S; U is N or CH ; Z is (CH2)m, 1,2-phenylene, CH=CH, COCH2 or CSCH2-; V is O, S, CH2, or NR<10>, wherein R<10> is hydrogen or alkyl; U<1> is O, S, CH2 or NR<11>, wherein R<11> is as R<10>; and V<1> is NR<12>R<13>, OR<14>, SR<15> or CR<16>R<17>R<18>, where each of R<12>-R<18> are as the R<10>-substituents; R<9> is hydrogen or alkyl; or R<9> is linked to R<7> to form a ring; or R<8> and R<9> together form a morpholinyl or piperidinyl ring, the latter optionally substituted by alkyl or a group of Formula 1a or 1b, or a carbamoyl group, show central antiserotonergic activity and possibly also antidopaminergic activity and are, accordingly, useful in the treatment of central nervous system (CNS) disorders. The compounds are prepared by methodt known pr. se.
申请公布号 JPH09506595(A) 申请公布日期 1997.06.30
申请号 JP19950516476 申请日期 1994.12.15
申请人 发明人
分类号 A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/445;A61P25/00;A61P25/04;A61P25/06;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P43/00;C07D209/10;C07D209/12;C07D209/14;C07D209/16;C07D209/30;C07D209/34;C07D209/36;C07D401/06;C07D401/12;C07D403/12;(IPC1-7):C07D209/10 主分类号 A61K31/40
代理机构 代理人
主权项
地址